BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1453 related articles for article (PubMed ID: 25887525)

  • 1. Correlation between psychological stress levels and the severity of overactive bladder symptoms.
    Lai H; Gardner V; Vetter J; Andriole GL
    BMC Urol; 2015 Mar; 15():14. PubMed ID: 25887525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Relationship Between Anxiety and Overactive Bladder or Urinary Incontinence Symptoms in the Clinical Population.
    Lai HH; Rawal A; Shen B; Vetter J
    Urology; 2016 Dec; 98():50-57. PubMed ID: 27450939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep Disturbance and Fatigue Are Associated With More Severe Urinary Incontinence and Overactive Bladder Symptoms.
    Ge TJ; Vetter J; Lai HH
    Urology; 2017 Nov; 109():67-73. PubMed ID: 28826875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of childhood and recent traumatic events on the clinical presentation of overactive bladder.
    Lai HH; Morgan CD; Vetter J; Andriole GL
    Neurourol Urodyn; 2016 Nov; 35(8):1017-1023. PubMed ID: 26332868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between depression and overactive bladder/urinary incontinence symptoms in the clinical OAB population.
    Lai HH; Shen B; Rawal A; Vetter J
    BMC Urol; 2016 Oct; 16(1):60. PubMed ID: 27716241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm.
    Ackerman AL; Lai HH; Parameshwar PS; Eilber KS; Anger JT
    BJU Int; 2019 Apr; 123(4):682-693. PubMed ID: 30253040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Nonurological Symptoms in Patients with Overactive Bladder.
    Lai HH; Vetter J; Jain S; Andriole GL
    J Urol; 2016 Aug; 196(2):467-72. PubMed ID: 26997309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Severity and Distribution of Nonurologic Pain and Urogenital Pain in Overactive Bladder are Intermediate Between Interstitial Cystitis and Controls.
    Thu JHL; Vetter J; Lai HH
    Urology; 2019 Aug; 130():59-64. PubMed ID: 31034917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of baseline severity of lower urinary tract symptoms with the success conservative therapy for urinary incontinence in women.
    Obloza A; Teo R; Marriott E; Parker G; Tincello D
    Int Urogynecol J; 2019 May; 30(5):705-710. PubMed ID: 30306193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Overactive Bladder Symptoms Among Women With Interstitial Cystitis/Bladder Pain Syndrome.
    Dubinskaya A; Tholemeier LN; Erickson T; De Hoedt AM; Barbour KE; Kim J; Freedland SJ; Anger JT
    Female Pelvic Med Reconstr Surg; 2022 Mar; 28(3):e115-e119. PubMed ID: 35272344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urgency severity scale could predict urodynamic detrusor overactivity in patients with overactive bladder syndrome.
    Chung SD; Liao CH; Chen YC; Kuo HC
    Neurourol Urodyn; 2011 Sep; 30(7):1300-4. PubMed ID: 21560153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials.
    DuBeau CE; Morrow JD; Kraus SR; Creanga D; Bavendam T
    Neurourol Urodyn; 2012 Nov; 31(8):1258-65. PubMed ID: 22907761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of bladder pressure and discomfort symptoms: How do overactive bladder differ from interstitial cystitis/bladder pain syndrome patients?
    Gousse A; Vetter J; Lai HH
    BMC Urol; 2023 Mar; 23(1):53. PubMed ID: 36997906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The overlap and distinction of self-reported symptoms between interstitial cystitis/bladder pain syndrome and overactive bladder: a questionnaire based analysis.
    Lai HH; Vetter J; Jain S; Gereau RW; Andriole GL
    J Urol; 2014 Dec; 192(6):1679-85. PubMed ID: 24907443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptions of "urgency" in women with interstitial cystitis/bladder pain syndrome or overactive bladder.
    Clemens JQ; Bogart LM; Liu K; Pham C; Suttorp M; Berry SH
    Neurourol Urodyn; 2011 Mar; 30(3):402-5. PubMed ID: 21412821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cues to urinary urgency and urge incontinence: how those diagnosed with overactive bladder syndrome differ from undiagnosed persons.
    OʼConnell KA; Torstrick A; Victor E
    J Wound Ostomy Continence Nurs; 2014; 41(3):259-67. PubMed ID: 24805178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.
    Dokmeci F; Cetinkaya SE; Seval MM; Dai O
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():126-131. PubMed ID: 28355584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder.
    Noblett K; Siegel S; Mangel J; Griebling TL; Sutherland SE; Bird ET; Comiter C; Culkin D; Bennett J; Zylstra S; Kan F; Berg KC
    Neurourol Urodyn; 2016 Feb; 35(2):246-51. PubMed ID: 25546568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clustering of patients with overactive bladder syndrome.
    Gross J; Vetter JM; Lai HH
    BMC Urol; 2021 Mar; 21(1):41. PubMed ID: 33740925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.